Max Krummel
Fondatore presso Foundery Innovations, Inc.
Profilo
Max Krummel was the founder of Pionyr Immunotherapeutics, Inc. (founded in 2015) and Foundery Innovations, Inc. (founded in 2021) where he held the title of Director and Managing Member respectively.
Currently, he serves as an Advisory Board member at Deciduous Therapeutics, Inc. (since 2021).
Dr. Krummel received his undergraduate degree from the University of Illinois in 1989 and his doctorate degree from the University of California in 1995.
Posizioni attive di Max Krummel
| Società | Posizione | Inizio |
|---|---|---|
Foundery Innovations, Inc.
 Foundery Innovations, Inc. BiotechnologyHealth Technology Foundery Innovations, Inc. develops transformative immunotherapies for immune-based diseases. The private company is based in San Francisco, CA. Foundery Innovations was founded in 2021 by Michel Streuli, Venkataraman Sriram, Max Krummel. Michel Streuli has been the CEO since 2021. | Fondatore | 01/01/2021 |
Deciduous Therapeutics, Inc.
 Deciduous Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Deciduous Therapeutics, Inc. engages in the biotechnology business. It develops novel therapies to activate the endogenous immune system to treat age related diseases. The company is headquartered in San Francisco, CA. | Consulente / Consigliere | 01/01/2021 |
Precedenti posizioni note di Max Krummel
| Società | Posizione | Fine |
|---|---|---|
Pionyr Immunotherapeutics, Inc.
 Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Pionyr Immunotherapeutics, Inc. develops cancer immunotherapies. It targets the tumor microenvironment to enhance the body?s antitumor immunity. The company was founded by Max Krummel and Sachdev Sidhu in 2015 and is headquartered in San Francisco, CA. | Fondatore | - |
Formazione di Max Krummel
| University of Illinois | Undergraduate Degree |
| University of California | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Pionyr Immunotherapeutics, Inc.
Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Pionyr Immunotherapeutics, Inc. develops cancer immunotherapies. It targets the tumor microenvironment to enhance the body?s antitumor immunity. The company was founded by Max Krummel and Sachdev Sidhu in 2015 and is headquartered in San Francisco, CA. | Health Technology |
Deciduous Therapeutics, Inc.
Deciduous Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Deciduous Therapeutics, Inc. engages in the biotechnology business. It develops novel therapies to activate the endogenous immune system to treat age related diseases. The company is headquartered in San Francisco, CA. | Health Technology |
Foundery Innovations, Inc.
Foundery Innovations, Inc. BiotechnologyHealth Technology Foundery Innovations, Inc. develops transformative immunotherapies for immune-based diseases. The private company is based in San Francisco, CA. Foundery Innovations was founded in 2021 by Michel Streuli, Venkataraman Sriram, Max Krummel. Michel Streuli has been the CEO since 2021. | Health Technology |
- Borsa valori
- Insiders
- Max Krummel
